People

5-Year-Old in ICU from Potentially Bad Batch of ADHD Medicine, 2 Other Children Hospitalized

At least three children ended up in the hospital after taking a liquid form of clonidine dispensed at a Kentucky pharmacy Google street view At least three children are in the hospital after taking a ...
WLKY

WLKY Investigates: 4-year-old recovering after dose of clonidine sends him to the hospital

AND SHE SPEAKS TO OTHER FAMILY DEALING WITH THE IMPACT. THIS IS FOUR YEAR OLD LEVI. THIS IS MY BIG BALL OF ENERGY. HE’S ALWAYS ON THE GO. BUT LAST WEEK, HIS MOM, JESSICA FIELDS, SAYS EVERYTHING ...

Azurity Pharmaceuticals Announces the Availability of JAVADIN™ (clonidine hydrochloride) Oral Solution

Approved, Ready-to-Use Clonidine Oral Solution for Hypertension Control in Adult PatientsWoburn, MA, Dec. 18, 2025 (GLOBE ...
The Courier-Journal

'We've got very angry parents': Henry County 5-year-old still recovering after medication error

Tabitha Drew felt helpless in late August as she watched her 5-year-old daughter, Raevyn Winters, go "completely lifeless" minutes after receiving her clonidine medication filled at a local Med Save ...
WHAS11 News

'I honestly thought my baby was dead': 5 year old in the ICU after a bad shipment of medication

HENRY COUNTY, Ky. — Editor's note: Tabitha Drew told WHAS11 News that her daughter has been released from the hospital and is back at home. A 5-year-old child is fighting for her life in the ICU on ...
WebMD

Alpha-2 Agonist Drugs for Kids With ADHD

When kids with ADHD need medicines to help with symptoms like hyperactivity, inattention, or impulsivity, doctors usually suggest stimulants first. But some children don’t respond well to these drugs ...
Monthly Prescribing Reference

Onyda XR, a Nonstimulant Liquid ADHD Medication, Now Available

Credit: Tris Pharma Onyda XR is supplied as an orange-flavored oral suspension containing clonidine hydrochloride 0.1mg per mL. Onyda XR is the first nonstimulant liquid ADHD medication with nighttime ...
Business Wire

Tris Pharma Receives U.S. FDA Approval for Once-Daily ONYDA XR (clonidine hydrochloride) Extended-Release Oral Suspension, the First-and-Only Liquid Non-Stimulant ADHD Medication

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Business Wire

Tris Pharma’s Once-Daily ADHD Medication, ONYDA XR (clonidine hydrochloride) Extended-Release Oral Suspension, Now Available in the United States

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
FiercePharma

Mylan Receives Approval for Generic Version of Catapres-TTS®

Clonidine Transdermal System had U.S. sales of approximately $313 million for the 12 months ending March 31, 2010, according to IMS Health. The product is available for immediate shipment. Currently, ...
FiercePharma

Boehringer Ingelheim quietly culls decades-old hypertension med after October recall

After a subpar testing result inspired Boehringer Ingelheim to pull multiple batches of a long-established blood pressure med, the company has decided to halt production for good. Three doses of ...